In particular, studies using mouse models revealed that exogenous administration of FGF21 induces a great number of metabolic effects in both, whole body and certain tissues, which are considered as beneficial with regard to prevention or treatment of obesity and T2DM [40–42]. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.